Sun Pharma share price target 2022 2023 2024 2025 2030

Sun Pharma share price target

About sun pharma : 

solar Pharmaceutical Industries Ltd. was incorporated within the yr 1993. Its today’s share price is 763.55. Its contemporary marketplace capitalisation stands at Rs 183069.26 Cr. inside the today’s quarter, business enterprise has mentioned Gross sales of Rs. 144695.6 Cr and general earnings of Rs.129647.6 Cr. The business enterprise‘s control consists of Sunil R Ajmera, Rama Bijapurkar, Pawan Goenka, Gautam Doshi, Rekha Sethi, Sudhir V Valia, Kalyanasundaram Subramanian, Sailesh T Desai, Dilip S Shanghvi, Israel Makov.
it is indexed at the BSE with a BSE Code of 524715 , NSE with an NSE image of SUNPHARMA and ISIN of INE044A01036. it is Registered office is at solar Pharma advanced studies Centre (S P A R C),Tandalja,Vadodara-390020, Gujarat. Their Registrars are ACC Ltd. it’s auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells, price Waterhouse, SRBC & Co LLP

Mkt cap1.83LCr
52-wk high851.00
52-wk low539.70
P/E ratio29.44
Div yield0.98%

Share Target Price 2022 2023 2025 2030 of Sun Pharma

Show 102550100 entriesSearch:


SunPharma share price target 2023

friends, if the target for 2021 is met. The inventory will upward push due to the sentiment of the public growing within the inventory and preserving the momentum up of the stock. And subsequently our prediction is 1206 and the second prediction goal is 1448. The simple cause for that is the recuperation for the financial system will take time and might retain till 2023 as properly.

SunPharma share price target 2024

using Fibonacci Retracement even supposing some times corrections do happen in the SunPharma inventory it should cross onto the degrees of 1567 and 1744. This prediction can be attributed to the reality that the company control has been very dependable. this would be glaring when we move over the Quarterly evaluation for SunPharma.

SunPharma share price target 2025

in case you do preserve the SunPharma inventory until 2025 the predicted ranges are 2084 and 2332. lengthy–time period protecting is recommended since it reduces danger, tax deductions, and additionally a hefty dividend (in case you select that option this is). Even with out dividends the returns could pretty generous.

SunPharma share price target 2030

SunPharma would likely reach the ranges of as a minimum 2640, the second one target for solar pharma percentage target 2030 is 3019 and the third target for sunpharma 2030 is 3551. this could be compounded by using the truth that the organisation is 2d in the Pharma zone in India in-phrases of size and as a protracted–time period investor this would mean a totally worthwhile go back for the funding.


Is sun PHARMACEUTICAL INDUSTRIES right for long time investment?
As on 09-Dec-2021, the basics of sun PHARMACEUTICAL INDUSTRIES appearance sturdy and for this reason it is able to be exact for long time investment! See financial performance of sun PHARMACEUTICAL INDUSTRIES . Please have a look at the other parameters which includes Valuation, charge Momentum, information & company Governance and/or consult an investment guide earlier than taking an funding decision!

Is sun PHARMACEUTICAL INDUSTRIES UnderValued or overestimated?
As on 09-Dec-2021, solar PHARMACEUTICAL INDUSTRIES is below Valued primarily based on the estimates of intrinsic fee and consequently may be a terrific buying possibility consistent with percentage Valuation at this time!

what is the Intrinsic cost of sun PHARMACEUTICAL INDUSTRIES ?
As on 09-Dec-2021, the Intrinsic cost of solar PHARMACEUTICAL INDUSTRIES is Rs. 1,125.41 determined primarily based on Median of the three ancient models.
honest value [Median EV / EBIDTA Model] : Rs. 735.62
fair value [Median EV / Sales Model] : Rs. 1,125.41
honest price [Median Price / Sales Model] : Rs. 1,164.14
Median fair fee of sun PHARMACEUTICAL INDUSTRIES : Rs. 1,125.41

Is sun PHARMACEUTICAL INDUSTRIES buying and selling at a top class or bargain?
As on 09-Dec-2021, sun PHARMACEUTICAL INDUSTRIES is buying and selling at a discount of -33% based at the estimates of Median Intrinsic value!

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top